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Abstract
Background: Non-adherence to tuberculosis (TB) treatment is an important barrier for TB
control programs because incomplete treatment may result in prolonged infectiousness, drug
resistance, relapse, and death. The aim of the present study is to explore enablers and barriers in
the management of TB treatment during the first five months of treatment in Addis Ababa, Ethiopia.
Methods: Qualitative study which included 50 in-depth interviews and two focus groups with TB
patients, their relatives and health personnel.
Results: We found that loss of employment or the possibility to work led to a chain of interrelated
barriers for most TB patients. Daily treatment was time-consuming and physically demanding, and
rigid routines at health clinics reinforced many of the emerging problems. Patients with limited
access to financial or practical help from relatives or friends experienced that the total costs of
attending treatment exceeded their available resources. This was a barrier to adherence already
during early stages of treatment. A large group of patients still managed to continue treatment,
mainly because relatives or community members provided food, encouragement and sometimes
money for transport. Lack of income over time, combined with daily accumulating costs and other
struggles, made patients vulnerable to interruption during later stages of treatment. Patients who
were poor due to illness or slow progression, and who did not manage to restore their health and
social status, were particularly vulnerable to non-adherence. Such patients lost access to essential
financial and practical support over time, often because relatives and friends were financially and
socially exhausted by supporting them.
Conclusion: Patients' ability to manage TB treatment is a product of dynamic processes, in which
social and economic costs and other burdens change and interplay over time. Interventions to
facilitate adherence to TB treatment needs to address both time-specific and local factors.
Background
Tuberculosis (TB) is a major public health challenge, with
an estimated 8.8 million new cases and 1.7 million deaths
in 2003 [1]. 27% of these cases and 31% of the deaths
occur in Africa, where case rates continue to rise. The situ-
ation in Africa has been attributed to the HIV epidemic
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and poorly organized TB control programs [1,2]. Treat-
ment of TB requires access to appropriate health care, but
patients may find it difficult to adhere to the intended
treatment even if such services are available. Studies from
both low- and high-income countries show that between
20% and 50% of patients with TB do not complete treat-
ment regimes [3,4]. Incomplete treatment may result in
prolonged infectiousness, drug resistance, relapse, and
death [5]. Improvement in treatment outcomes requires a
better understanding of the barriers and enablers patients
experience during TB treatment. Quantitative and qualita-
tive studies from countries in Asia and Africa point to bar-
riers related to availability and accessibility [6-8], and
direct and indirect costs related to treatment [9-12].
Inconvenient routines in health care systems [13-15] and
interaction with health personnel may also act as barriers
[13,16-18].
In Ethiopia, where there is an increasing incidence of new
infectious TB cases [19], quantitative studies from rural
areas found that between 6.7% and 20% of patients inter-
rupted treatment and that long distances to the health
facilities, poor awareness about the disease and treatment
length, side effects and lack of family support are impor-
tant factors [20-23]. An early case control study from
Addis Ababa found that "social problems" and "feeling of
improvement" were major causes of treatment interrup-
tion [24]. These studies found that most patients inter-
rupted treatment in the third or fourth month.
Few studies have used qualitative methods to explore
patients' experiences during different phases of treatment,
and to the authors' knowledge the studies on diagnostic
delay and treatment interruption in Ethiopia have not
been explored further in qualitative research.
WHO has emphasized that an important research area is
identifying time points in the treatment that are of impor-
tance for different types of adherence strategy [25]. The
aim of the present study is to explore enablers and barriers
in the management of TB treatment during the first five
months of treatment in Addis Ababa, Ethiopia.
Methods
We used qualitative methods to explore enablers and bar-
riers in the management of TB treatment. We found that
in-depth interviews conducted during different stages of
treatment were the most appropriate method for explor-
ing how context-specific enablers and barriers interact
over time. We used focus group discussions for further
exploration and validation of information from the in-
depth interviews. The study comprised a follow-up study
with three individual in-depth interviews of 10 newly-
diagnosed TB patients, in addition to one single individ-
ual interview with 11 TB patients who had interrupted
treatment. We also interviewed two TB patients who were
on re-treatment, four relatives, five health care staff, and
conducted focus group discussions involving 11 TB
patients currently undergoing treatment.
Study setting
Data was collected over a six-month period in Addis
Ababa, the capital of Ethiopia, in 2001–2002. At this time,
Addis Ababa had about 95% coverage of directly observed
treatment, short course (DOTS) in existing governmental
health facilities [26]. TB treatment involved daily attend-
ance for two months (the intensive phase), followed by a
period of six months during which medicines were col-
lected once or twice a month (the continuation phase). At
the time of the study, HIV counselling and testing was not
routinely carried out for TB patients. Anecdotal reports
and clinical observations suggested a high rate of co-infec-
tions, and according to the Ethiopian Ministry of Health
AIDS patients occupied about 42% of existing hospital
beds [19,27]. The number of TB patients not completing
their full course of treatment was difficult to estimate, as
only a proportion of smear-positive patients were evalu-
ated for their outcome [26].
Study sites
Participants were recruited from three sites: (i) Woreda 23
Health Centre, a centre for TB diagnosis and treatment
located about two kilometres from the ALERT (All African
Leprosy and Rehabilitation Training Centre) hospital; (ii)
St Peter's TB Specialized Hospital Outpatient Service,
which offered diagnostic and treatment services and was
located in the Kolfe area; (iii) and Kebele 16 Health Post,
which provided TB treatment but was without diagnostic
facilities (patients were diagnosed at Woreda 23 Health
Centre). This health post was located in a slum area close
to the ALERT hospital and training centre. (A Kebele is
part of a Woreda and is the smallest administrative unit in
Ethiopia.) These research sites where chosen based on
advice from local researchers at Armauer Hansen's
Research Institute (AHRI) and from WHO's TB/Leprosy
advisor at the Ministry of Health in Ethiopia. The sites
were considered to be "typical" DOT (directly observed
treatment) clinics, but they were also chosen because they
represented diversity being located in different areas of
town. The three sites had similar routines related to daily
TB treatment (DOT).
Participants and data collection
The study included both TB patients who were attending
TB treatment and TB patients who had interrupted TB
treatment. Newly diagnosed TB patients ("new cases")
were approached by means of an invitation letter distrib-
uted by health personnel at Woreda 23 Health Clinic. A
purposeful sample of 10 patients; five men and five
women aged 18 to 67 years, participated in the prospec-BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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tive part of the study. Two patients declined to participate
because they were too ill. Participants' characteristics are
displayed in Table 1. There were difficulties with tracing
patients who had interrupted treatment, due to lack of, or
incorrect, addresses. St Peter's TB Specialized Hospital
Outpatient Service and Kebele 16 Health Post were there-
fore included for the purpose of recruiting patients who
had interrupted treatment. We traced 11 patients that had
been on treatment for at least two weeks, and had inter-
rupted treatment for more than six consecutive weeks at
the time of contact. All eleven patients agreed to partici-
pate in the study. The group consisted of six men and five
women, aged 20 to 60 years. Participants' characteristics
are displayed in Table 1. The National Tuberculosis and
Leprosy Control Program (NTLCP) restricts its definition
of defaulters to patients who have attended treatment for
at least four weeks and have been absent for at least eight
consecutive weeks or for a cumulative period of 12 weeks.
All of our participating patients do thus not meet the for-
mal definition of a defaulter. Focus group participants
were recruited by the first author and the research assist-
ant from all three clinics.
We developed an interview guide that covered general
beliefs about TB and TB treatment, as well as time-specific
factors that could affect the management of treatment.
The guide was inspired by Becker's [28] review of models
and strategies to find consistent predictors of adherence.
Becker suggests that certain health beliefs, together with
the psychological and other perceived costs of the recom-
mended action, the interaction between patients and
health service deliverers, and other types of social influ-
ence, are important dimensions for understanding adher-
ence.
Ethics
Informed oral or written consent was sought in all cases.
De-identification and confidentiality were ensured by
using numbers and fictitious names to describe and iden-
tify patients. Ethical approval for the study was obtained
from the Regional Committee for Medical Research Ethics
in Norway and the National Ethical Clearance Committee
in Ethiopia.
Individual in-depth interviews
The first author (MS) conducted face-to-face, tape-
recorded, qualitative, in-depth interviews. The questions
and answers were translated from English to Amharic and
vice versa by a local research assistant/interpreter. All
interviews took place at locations chosen by the patients.
The interviews lasted from two to three hours. Questions
in the interview guide were open-ended, and emerging
themes and hypotheses from earlier interviews were
explored in subsequent interviews. 10 TB patients were
interviewed three times over a period of five months. The
first in-depth interview was conducted two weeks after
diagnosis, the second interview two months later and the
third interview five months into treatment. All patients,
except one who died, participated in all three interviews.
A single individual in-depth interview was conducted
with each of the 11 patients who had interrupted treat-
ment. Other groups of informants, like relatives of
patients that died after treatment interruption, and
patients on re-treatment, were also interviewed. In-depth
interviews were additionally conducted with two nurses
and one doctor from Woreda 23 Health Centre, one nurse
from Kebele 16 Health Post and one nurse from St Peter's
TB Specialized Hospital Outpatient Service. These individ-
uals were recruited because they were managing TB
patients on a full-time basis. Participants' characteristics
are displayed in Table 2.
Focus groups
Two focus group discussions with TB patients who were
undergoing TB treatment were arranged after the in-depth
interviews were completed. Patients with different educa-
tional backgrounds were chosen [29], yet with adjust-
ments to personal features and the group composition as
a whole. One group consisted of five female TB patients,
the other of six male TB patients. Participants' characteris-
tics are displayed in Table 3. The focus group discussions
lasted for two hours, and were moderated by the research
assistant, who was trained in focus group interview prin-
ciples and techniques. The first author introduced pre-
Table 1: Characteristics of 10 patients undergoing treatment and 
11 patients who had interrupted treatment who were 
interviewed individually
Characteristic Undergoing 
(n = 10)
Interrupted 
(n = 11)
No. No.
Gender
Male 5 5
Female 5 6
Age
< 25 3 2
26–35 6 6
> 36 1 3
Education
Partly illiterate/illiterate 1 4
1–6 years 3 3
7–10 years 1 2
11–13 years 5 2
Occupation
Daily labourer* 2 3
Civil servant 2 1
Private sector 3 4
Other 3 3
* Person who is not employed on a permanent basis, but who may 
meet at a regular point every day to compete with others to be hired 
for the day.BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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selected topics related to common, discrepant or particu-
larly interesting findings from the in-depth interviews for
further validation. Notes were taken, and the discussions
were tape-recorded.
Analysis
Use of an interpreter during interviewing creates a poten-
tial source of misunderstanding. We actively sought to
prevent errors by continuously discussing and negotiating
the content of key words, broader concepts and units of
meaning. The first author and the research assistant/inter-
preter thoroughly discussed and clarified the content of
each tape-recorded interview. Clarifying notes were added
and main themes and issues to be explored in subsequent
interviews or focus groups were systematically written
down (conceptual maps). A "memo" (notes on each par-
ticipant, including main content of the interview) was
made enabling the second and third author to read about
each of the participants that were interviewed and quoted
in the manuscript. The research assistant translated and
transcribed verbatim each interview and the discussions
in the focus groups. All transcriptions were manually
coded within a defined coding frame. The coding frame
was developed on the basis of Becker's theories [28], and
was informed by themes and issues emerging from the
material. Data concerning factors that affected patients'
management of TB treatment was used for systematic text
condensation, according to the principles of Giorgi's [30]
phenomenological analysis, modified by Malterud [31].
The analysis followed these steps: (i) reading all the mate-
rial to get an overall impression; (ii) identifying units of
meaning that represent different factors that influence the
management of TB treatment, and coding for these; (iii)
condensing and summarizing the content of each of the
coded groups; (iv) integrating the insights from the con-
densed meaning units into generalized descriptions that
reflect apparently significant factors. The analysis was
summarized and accounted for in an analysis document
that all authors commented on.
Results
We found that loss of employment or the possibility to
work led to a chain of interrelated barriers for most TB
patients. Daily treatment was time consuming and physi-
cally demanding, and rigid routines at health clinics rein-
forced many of the emerging problems. Patients with
limited access to financial or practical help from relatives
or friends experienced that the total costs of attending
treatment exceeded their available resources. This was a
barrier to adherence already during early stages of treat-
ment. A large group of patients still managed to continue
treatment, mainly because relatives or community mem-
bers provided food, encouragement and sometimes
money for transport. Lack of income over time, combined
with daily accumulating costs and other struggles, made
patients vulnerable to interruption during later stages of
treatment. Patients who were poor due to illness or slow
progression, and who did not manage to restore their
health and social status, were particularly vulnerable to
non-adherence. Such patients lost access to essential
financial and practical support over time, often because
relatives and friends were financially and socially
exhausted by supporting them. These findings are
grouped into main themes and examined in further detail
below.
Loss of income
The majority of patients in the study experienced loss of
employment or the opportunity to work as one of their
main problems during treatment. Patients reported losing
their job when their TB diagnosis was known, or because
they were too ill to continue working, or were unable to
find daily work because of the time consuming treatment
arrangements. Three patients were housewives, but the
Table 3: Characteristics of 11 patients who were undergoing 
treatment and who were interviewed in focus groups
Characteristic No.
Gender
Male 6
Female 5
Age
< 25 4
26–35 4
> 36 3
Education
Partly illiterate/illiterate 2
1–6 years 3
7–10 years 4
11–13 years 2
Occupation
Daily labourer 3
Civil servant 3
Private sector 2
Other 3
Table 2: Characteristics of 5 health personnel and 6 other 
participants who were interviewed individually
Characteristic Health personnel 
(n = 5)
Others 
(n = 6)
No. No.
Gender
Male 3
Female 2
Education
Nurse 4
Medical doctor 1
Relatives of patients 4
Patients on re-treatment 2BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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household finances were still affected because their hus-
bands lost income and risked their jobs escorting them to
the clinic. One of the husbands explained:
"I tried to explain for them that I was the only one working in
our family, so I couldn't go every morning ... because in that
way I would lose my job and me and my wife would die of hun-
ger. I work in the private sector and it is difficult to get permis-
sion every day." (Participant 24, prospective group.)
Patients who worked in the private sector and "daily
labourers" (a person who is not employed on a perma-
nent basis, but who may meet at a regular point every day
to compete with others to be hired for the day) were most
affected. Also health personnel identified these groups as
particularly vulnerable:
"People who are daily labourers or work in the private sector
they can't get any kind of [sick] leave and they face more prob-
lems. Many of them interrupt treatment because they don't
want to lose their jobs. They rather live for a while, with money
and their jobs, to eat and then die." (Participant 27, male
nurse.)
Being ill and without access to any health care benefits
often resulted in a loss of income from one day to the
next. Patients' situations were aggravated because loss of
income coincided with additional expenses. More than
half of all the patients had been treated at private clinics
before entering conventional TB treatment, paid for from
savings or money borrowed from relatives or community
members. Daily attendance at a clinic caused high trans-
portation costs, and those that could not afford transpor-
tation incurred opportunity costs due to extensive time
use. In addition, most patients believed that they had to
eat expensive protein food like meat, milk and eggs to get
cured. A daily labourer offered an illustration of how the
struggle to obtain "good food" increased his already pro-
nounced personal crisis caused by loss of income:
"How can I get this food [good food], it is impossible to get this.
I don't have a job. [...] "I'm even considering committing sui-
cide. [...] I have lost all hope ... totally. I am the one that sup-
port me and now I can't support myself. I can't work, and then
it is hard for me to survive." (Participant 10, male patient, pro-
spective group.)
Loss of income combined with additional costs made TB
patients' particularly vulnerable during the first period of
treatment (the intensive phase). Two patients in the pro-
spective group continuously considered interrupting
treatment due to a lack of money for food and transporta-
tion to the clinic.
Hunger
Impoverishment due to loss of income caused unpredict-
ability and emotional stress in relation to daily access to
food. Many participants described feeling chronically
hungry, suffering the slow starvation of people who eat a
little bit every day but whose hunger is never fully satis-
fied. A young male patient, who lived with his single, TB
inflicted mother, was too ill to continue working as a daily
labourer. He related how lack of food made him lose his
motivation to follow the treatment:
"Q. During the last weeks, have you ever considered not to go
to the health centre?"
"Yes, I thought about that many times ... on and off. Especially
when I lack food I feel like not coming. [...] My only motivation
is to get food ... food ... it is food that is motivating me [...] to
get food, any kinds of food ... at the right time ... and to have a
person that can help you get that food." (Participant 8, male
patient, prospective group.)
Chronic hunger induced a feeling of hopelessness among
patients. Irregular and insecure access to food over time
made many lose their hope of recovering and avoiding
death.
Taking medicines on an empty stomach
Gastritis was the most common side effect, and was
reported by nearly all intensive-phase patients. The symp-
toms were described as a burning or gnawing pain in the
abdomen. A few patients explained that they pretended to
swallow the medicines, saving them until they could take
them with food or milk. A female focus group participant
explained:
"I knew that I would feel the pain if I swallowed the tablets
immediately [at the clinic]. Therefore I pretended swallowing
the tablets. I took the tablets, hiding them. Then I swallowed
the tablets later ... with milk ... at home." (Female focus group
participant, focus group one.)
Patients attributed side effects, such as gastritis, nausea,
and vomiting, to taking strong medicines on an empty
stomach. These side effects had a large psychological
impact: Since most patients considered access to food,
and particularly food with a high content of protein, as
extremely important to healing, symptoms as gastritis
served as a continuous reminder of their poverty and what
they considered to be poor healing conditions.
Physical demands
Most patients complained that the first two months of
treatment were physically exhausting. This was particu-
larly the case for the many patients who were at advanced
stages of the disease at the time they started treatment.BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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Patients attending treatment at Kebele 16 Health Post had
shorter walking distances than those attending the other
clinics. This was a tremendous advantage for the many
who could not afford transportation. Most patients from
the other two clinics reported using one to two hours each
way. A patient with advanced symptoms, and who was
also suffering from various side effects, described her daily
walk to the clinic:
"Q. Do you always walk or do you take any kind of transport?"
P. "I walk, I don't have any money for transport."
"Q. Is it hard?"
P. "Yes, it is a bit far. I use almost two hours and I vomit on the
way." (Participant 5, female patient, prospective group.)
Once at the clinic, patients often waited an hour or more
to get their medication. This delay was mainly caused by
intensive-phase patients being told to attend at the same
time in the morning. This time-consuming system was
described as humiliating by some of the patients.
Rigid routines and health staff attitudes
The three clinics in the study practised DOT without tak-
ing into consideration that many patients were not physi-
cally able to come to the clinic. Many patients told how
they had begged to be hospitalized, but due to a lack of
hospital beds this option was out of the question for
many. One patient died on the 59th day of treatment,
having been refused medical attendance before the 60th
day, in accordance with clinic routines. Her husband
described how they had struggled to make health person-
nel understand that she was far too ill to walk to the clinic:
"We went to the clinic to ask if the nurse could give her the
medicines, at least once in seven days, telling him that our
house was far away [...] and explaining them that she was too
weak to go to the clinic every day ... she couldn't walk at that
time. The nurse didn't understand, rather he threatened her
saying he would demand her to come and collect the medicines
no matter how ill she was." (Participant 24, prospective group.)
In a few cases, relatives were allowed to collect the medi-
cines on behalf of very ill patients. This, however, put the
relatives' jobs in jeopardy, as they had to queue at the
clinic every day. In most cases, the patients were escorted
to the clinic by relatives. This incurred transportation and
opportunity costs for two persons, often within the same
household. The clinics allowed no exceptions for family-
or cultural events, and were highly inflexible as regards
patients trying to combine daily treatment with work-
related activities. Only one patient in the prospective
group managed to hold on to his job. He explained the
repeated difficulties he faced trying to balance the
demands of work with the treatment arrangements:
"Once I came late and I met the bad nurse ... and he was angry
about it. He told me to sit and wait for him until he got back
from town, just to give me my medicines. After he warned me
not to come late anymore and then he gave me the medicines.
He said, 'next time you will be given the injections even later
and you will be very late for your work'." (Participant 6, male
patient, prospective group.)
Some nurses were more flexible than others, but there
were examples from all three clinics of patients who were
threatened, humiliated or treated angrily by staff for not
adhering to the implicit rules of the system. At one of the
clinics, two patients reported that they had been denied
access after a period of interruption.
Dynamics of social support
The support of family and community members was
extremely important during the intensive phase of treat-
ment, because this to a large extent compensated for loss
of income. Even though TB caused fear and stigmatiza-
tion, people shared resources in a time of crisis, and recip-
rocal arrangements provided most TB patients with some
food. Many received physical support in walking to the
clinic, and some received money for transportation. A
male patient who lost his job as a car washer explained
how the contributions of relatives and community mem-
bers helped him:
"Even if I can't get good food I try to get as much food as possi-
ble. People who visit me bring me food ... neighbours and rela-
tives." (Participant 9, male patient, prospective group.)
Many patients experienced changes in the level of support
as the treatment program progressed. A male patient, who
lost his job as a temporary teacher, moved to live with rel-
atives in a rural area after completing the intensive phase.
His friends and grandmother no longer had the means to
help him:
"She [grandmother] couldn't afford to help me anymore. She
couldn't help me because of her shortage. They are all fed up
[...] I have moved, walked from place to place ... and there is
no food. In the rural area, even if my father is poor, I at least
managed to get milk from the neighbourhood." (Participant 1,
male patient, prospective group.)
Many patients faced difficult situations after completing
the intensive phase of treatment, as the levels of support
dropped. Both patients and health personnel reported
that the causes of the changes in support levels were
closely related to practical and symbolic changes in treat-
ment at this stage.BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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Crisis precipitated due to completion of the intensive 
phase
Based on a synthesis of the various sources of data we
found completion of the first phase of treatment to pre-
cipitate changes, often critically affecting existing support
mechanisms: First, patients were expected to stop going
for treatment on a daily basis, and were not expected to
need money for transport or help with walking to the clin-
ics. These changes reduced the attention focused on their
difficulties, and their needs therefore became less visible.
Second, it was expected that the health status of patients
who had finished the streptomycin injections, which were
considered the "main" medicine, should improve signifi-
cantly. Third, physical improvement was associated with
the expectation that patients would start to work again.
Fourth, the foods provided from the community were
expected to make a physical difference in patients. There
is a strong association between TB and HIV/AIDS, and
patients with a "curable disease" are expected to gain
weight and strength within a certain period of time.
Patients with prolonged disease (intermittent symptoms
or no weight gain) may be treated as having an incurable
disease (AIDS or a "chronic" type of TB), a condition that
carries additional stigma.
Six out of 10 patients in the prospective group, all still
financially dependent on others, experienced increasing
problems in mobilizing enough help in the period
between the second and fifth months. Some gradually
received less food, others were told to leave the house
because they were no longer able to contribute with the
rent. The experience of one patient, who still displayed
symptoms as skinniness and weakness during the contin-
uation phase, is illuminating. He reported how his rela-
tionship with his brother and sister-in-law became
increasingly tense because he could no longer pay his
share of the food and rent. He was told to leave in his fifth
month of treatment:
"People will get bored of you. Earlier they supported me when
they had money, or with some food, but they don't do that much
more. I can't ask for help all the time. (Crying) It is at home ...
they have asked me to leave their house now." (Participant 10,
male patient, prospective group.)
Relatives and community members may start to interpret
the slow recuperation process negatively, as indicating
eventual death, or they may assume that the patient will
not mange to re-establish his or her income. The basis of
reciprocity is taken away both when a patient become
totally dependent either permanently or for a prolonged
period of time, and when people think that the patient is
dying. When health personnel were asked about their
experiences related to treatment interruption, they all
mentioned patients leaving to live with relatives in rural
areas as one of the main causes. This was seen as a conse-
quence of patient-relative relationships being financially
or emotionally exhausted in the later stages of treatment.
Interplay of factors
Attending TB treatment brought with it various struggles
to meet the physical, psychological and financial costs of
treatment. Interviews with patients who had interrupted
treatment also demonstrated the interplay of such factors.
Five patients interrupted during the intensive phase of
treatment, two of them with only a few days left. Six
patients interrupted between the third and sixth months
of the continuation phase. Only one patient pointed to a
single factor as the cause of treatment interruption. This
patient was denied a sufficient ration of medicine to ena-
ble her to travel to the place where her son just had been
murdered. The causes of interruption were different, but
interrelated. They often operated over time and were most
often related to financial constraints. Three examples that
illustrate identifiable patterns in treatment interruption
are presented below.
Case one
A single mother, a working immigrant from a rural area,
used to beg outside one particular church before and after
morning mass. She had a small but regular income from
regular church visitors. Due to DOT, which takes up the
morning hours, she couldn't do that anymore, and her
only source of income was dramatically reduced. As a
result, she was unable to pay for the room she rented, and
she and her baby ended up on the street. She turned to the
health personnel, telling them that she was starving and
that she needed to take the medicines with her to her
mother in the countryside. Her request was denied, and
she decided to leave without the medicines after two
weeks of treatment:
"I didn't intend to interrupt the medicines at that time, but I
was too poor to keep on taking the medication. I was told to eat
eggs, meat and to drink milk, but the truth was ... I didn't even
have injera [Ethiopian pancake]. I went to the countryside
because I was forced to go there." (Participant 19, female
patient, retrospective group.)
This case illustrates how poor patients without rights to
paid sick leave or access to financial support from family
and friends experience acute and unbearable financial cri-
ses during early stages of treatment.
Case two
A male TB patient interrupted treatment shortly before
completing the intensive phase. During treatment, he
made intensive efforts to find daily work, but his physical
condition and the time-consuming system made this dif-
ficult. He often had no money for transport, and he feltBMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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weak and tired from having to walk four kilometres twice
a day. Sometimes he was late for treatment, which made
the health personnel angry. After about a month and a
half, he experienced that the friends who had helped him
the most became more reluctant to support him with
money. At the same time his relatives, all living in a rural
area, invited him to a funeral. He asked the health person-
nel to be allowed to attend, but this request was denied.
He decided to leave, interrupting treatment. When asked
why he interrupted, he gave several reasons:
"P. I didn't finish the treatment because I had to work to get
food and I was told to eat anything possible for the medication
and for the disease ... otherwise the medicines can't work ...
and to get food I had to work. The other thing was that I didn't
have money for transport to come to the clinic and I couldn't
walk always because I would be too late by the time I arrived at
the clinic. [...] I felt weak by walking to the clinic everyday, and
the insult of health personnel discouraged me.
Q. Would you say this whole situation made you go to your rel-
atives?
P. I went there because I was obliged to go there. (Pause) But I
was not motivated to come on foot to the hospital anymore."
(Participant 13, male patient, retrospective group.)
This case illustrates the situation where a patient ends up
in a vicious circle, where the demands of treatment
become more and more difficult to handle. A funeral or a
sick relative then represents a breaking point; a legitimate
way out of daily and accumulating struggles.
Case three
A young girl interrupted treatment after four and a half
months. At the time she started the medication, she was
too ill to walk to the clinic, and her mother collected the
medicines every day on her behalf. The time the mother
spent on daily attendance and nursing her daughter made
it impossible for her to work, and both mother and
daughter became totally dependent on food provided by
their neighbours. After two months of daily treatment, the
community members expected them to manage on their
own again. However, re-establishing herself as a beggar
and laundry washer proved difficult for the mother, and
as she was the only breadwinner, she became unable to
feed all her children. Desperation and hunger made the
sick girl break with the established social norms of the
community by begging in her own neighbourhood. This
led to unbearable fights with her mother:
"I started with the treatment, but after a while I felt so hungry
and the shortage of food at home ... and because I felt like men-
tally disturbed taking the medication ... made it impossible for
me to continue. On top of that my mother treated me so badly
at home. To overcome the shortage of food at home I started to
beg food and money from the neighbourhood. This begging
thing made my mother really mad. She said I was humiliating
her. We had some really big fights and after that I escaped from
home." (Participant 21, female patient, retrospective group.)
This case illustrates how prolonged illness may affect rela-
tions with relatives and community members. Weeks or
months of involuntary dependency force patients into
humiliating situations, while relatives and friends may
suffer from social or financial exhaustion.
Discussion
What does this study add to previous knowledge?
This study suggests that patients' management of treat-
ment is a product of dynamic processes and that patient's
behaviours respond to the complex patterns of socio-eco-
nomic and psychological factors during the course of
treatment.
The effect of time per se on adherence behaviour is
described by Christensen-Szalanski and Northcraft [32].
They point to the importance of understanding patients'
temporal perception of costs and benefits, and how tem-
poral perceptions may be influenced by delayed benefits
and accrued costs. We found that most patients experience
a chain of interrelated barriers during the intensive phase
of treatment. This chain is often activated by loss of
income and followed by lack of money for transport;
extensive time use; daily physical demands; food insecu-
rity; side effects and hunger. Rigid routines related to daily
attendance exacerbate many of these problems. TB
patients loosing their jobs and the opportunity to work
has been reported both in other parts of Ethiopia and in
other countries [6,12-14,33,34]. A study from Addis
Ababa [35] reported walking distances up to two hours
and found that the distances from patients' homes to the
health centres contributed to diagnostic delay. The author
underlines that the same factor may seriously affect TB
patients' ability to attend daily treatment.
We found that barriers in the intensive phase are managed
by most patients, albeit in different degrees, partly deter-
mined by the extent of financial and practical support
from family and neighbours. The protective effects of fam-
ily support have been found in other studies [6,10,33,36].
One study indicates that initially strong family support
became weaker during treatment [14]. Our study suggests
that patients who have fewer human or material resources
available in their environments, such as the very poor, sin-
gle mothers, and working immigrants from rural areas, do
not benefit from such protective factors. Some of these
patients may be forced to change their strategy and, as
related in this study, forced to move in with relatives inBMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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other areas due to acute financial crisis that arise even dur-
ing the early stages of treatment.
We found that a decision to interrupt TB treatment may be
taken in response to social obligations, such as attending
a funeral. A study from Addis Ababa [24] found illness of
relatives and attendance at funerals to be two of the most
frequently cited reasons for treatment interruption. Even
if such decisions are triggered by strong social norms, they
may be shaped by past struggles and accrued costs, which
may seem unbearable at the moment the decision is
taken. Hungry patients who lack the strength or motiva-
tion to continue treatment have also been found else-
where [37]. Previous studies from Ethiopia have found
that most patients interrupt in their third or fourth month
of treatment [22-24]. One study [23] found lack of family
support to be one of the major causes of interruption, and
this is supported by the findings in this study: Many
patients ended up in a vicious circle, where poverty and
possible co-infections (HIV) led to slow recovery, and
where slow recovery contributed to income poverty and
further dependency. These barriers manifested themselves
at a time when psychological and other costs had accumu-
lated, and enablers like family and community support
were decreasing. This study shows that illness-induced
poverty over time threatens the sustainability of house-
hold finances, as well as the social relations that serve as
the basis of the household's continued existence as a
social unit.
Our findings suggest that it is important that the health
care system is aware of the dynamics of social support
mechanisms. In Ethiopia there seems to be a change dur-
ing treatment from a "generalised" to a more "balanced"
type of reciprocity. This movement seems to be consistent
with symbolic and practical changes related to comple-
tion of the first stage of treatment (the intensive phase),
but may also be a product of increasing HIV/TB co-infec-
tion rates. In people's experiences, patients with pro-
longed diseases or intermittent symptoms often die, and
social support may therefore now be withdrawn earlier
than before.
Validity and transferability
The trustworthiness of the study and validity of our find-
ings is strengthened by the extensive triangulation within
the study. We interviewed different groups of patients,
health professionals and patients' relatives. The same
themes were investigated from both a prospective and a
retrospective angle, by means of different methods. Our
findings are characterized by similarities within and
between different groups of respondents and we believe
this strengthen the internal validity of our study.
The sample size is limited and restricted to one geograph-
ical area, and instead of proposing that the findings are
transferable to other contexts, we suggest using the con-
cept of "extrapolation" [38] to describe the usefulness of
our study. Patterns of findings presented in a broad con-
textual frame enable us to be aware of potential similari-
ties in similar contexts, in particular how variables may
interrelate at time-specific points in treatment and how
certain identifiable patterns may create barriers in relation
to the management of treatment.
TB control managers and others may argue that by not
strictly following NTLCP's operational definition of a
defaulter the findings will be less applicable. We believe
the implications are few since the strict definition is
mainly used to separate between defaulters who re-enters
treatment being smear positive again, and patients that
may recommence treatment to finish the initial regimen.
An important implication though may be increasing
awareness of patients that may "default" due to poverty
related barriers early in treatment (< 4 weeks), but that are
not registered as defaulters. The criteria used for defining
defaulters may result in relatively low overall rates of
default, also pointed to in another study from Ethiopia
[23].
Implications for practice
To our knowledge there are few major changes in how the
DOT services are organized in Addis Ababa. One change
that has been made is the establishment of a formal col-
laboration between services related to TB and services
related to HIV/AIDS [39]. However, a recent study exam-
ining the acceptability of HIV testing among TB patients,
conclude that the acceptability is low, and that it poses a
challenge to the scale-up of TB/HIV collaborative efforts
[40]. The findings in the present study may help to predict
treatment interruption during the early stages of treat-
ment, based on patients' socioeconomic and environmen-
tal conditions. Some of the barriers patients experience
during the intensive phase could easily be solved with
more flexible approaches, such as more flexible hours for
attendance and greater flexibility related to participation
in important cultural and family-related events. A primary
nurse-patient system, where patients are followed up by
the same nurse, would help health personnel to identify
each patient's resources and constraints. More individual
approaches will make it easier to establish relations based
on trust, and will facilitate flexible adjustments by means
of follow-up talks throughout treatment.
We believe that TB programs need to address nutrition. As
recognized by many patients, without food medical treat-
ment is in vain. Providing one glass of milk or a small
meal at the clinic could have a positive influence on both
case detection rates and treatment completion. By ensur-BMC Public Health 2008, 8:11 http://www.biomedcentral.com/1471-2458/8/11
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ing access to some nutritious food, patients may gain
weight and recover faster, probably the best way to fight
stigma and to strengthen social support mechanisms dur-
ing later stages of treatment. Initiating a dialogue with
labour organizations to help prevent TB patients losing
their job is another important step.
Still, many patients will experience difficulties related to
daily attendance. Further decentralization of TB-related
health care, use of mobile clinics, the provision of trans-
port money and permitting some of the poorest or most
ill patients to take tablets home for self-treatment may be
means to increase adherence. A recent review of rand-
omized controlled trials, comparing DOT with self-
administration of therapy, provides no evidence that the
routine use of DOT in low- and middle income countries
improves cure or treatment completion in people with
tuberculosis [5]. Several authors have advocated a shift in
perspective, where patients' socioeconomic environ-
ments, their well-being's and their dignity are included in
future strategies [2,41,42]. Strategies based on self-treat-
ment can be strengthened by support and supervision by
an identified relative or neighbour, or through other
social structures. Several TB control programmes that
leave the choice of DOT supervisor to the patient have
been shown to be successful [43-45].
In order to enable patients to get well, one need to make
an assessment of what formal and informal sources of
support exist, what structures are missing, and how differ-
ent contributors can fill the gap [2]. In Ethiopia, the
involvement of social support structures beyond relatives
seems to be important. One useful structure could be the
edir, a community based body with social responsibility
(mainly for arranging funerals) for those living within a
defined community (Kebele). The edir  could become
involved through the appointment of persons to be in
charge of supporting TB patients who are unable to attend
treatment on a daily basis. Social support structures could
also be established based on the model of the successful
"TB clubs", which are small groups of patients who live
near each other, implemented in some rural parts of Ethi-
opia. These clubs, which collaborate with health workers
and key persons in the community, have become an inte-
gral part of the tuberculosis program by referring sus-
pected cases, promote treatment adherence and trace
patients who interrupt [33,46]. Existing community
mechanisms can be strengthened by involving the com-
munities and creating a climate of awareness and shared
responsibility for solving major health issues. By involv-
ing the communities, more flexible arrangements can be
facilitated, the treatment burden can be reduced, and a
better balance can be ensured between control measures
and enabling measures.
Conclusion
Patients' ability to manage TB treatment is a product of
dynamic processes, in which various social and economic
costs and other burdens change and interplay over time.
Interventions to facilitate adherence to TB treatment need
to address both time-specific and local factors.
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